This is a non-core endpoint: only basic statistics are computed.
Serous carcinoma of ovary
C3_OVARY_SEROUS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleonly females |
293218 |
2. Check conditionsNone |
293218 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
243 |
4. Check minimum number of eventsNone |
243 |
5. Include endpointsNone |
243 |
6. Filter based on genotype QC (FinnGen only) |
232 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Serous carcinoma of ovary
based on the number of shared cases.
Similar with more cases:
- Serous carcinoma of ovary, including Hilmo
- Malignant neoplasm of ovary
- Malignant neoplasm of ovary, including Hilmo
- malignant neoplasm of female genital organs
- Solid cancers, helper endpoint
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 232 | 232 | - |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | - |
| Median age at first event (years) | 59.81 | 59.81 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 243
- Matched controls
- 2430
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8441/3-C56.9
ICD-O-3
Serous carcinoma, NOS, of ovary
+∞
307.7
243
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
245.4
192
*
H02AB02
ATC
dexamethasone; systemic
103.7
186.6
99
16
A04AA01
ATC
ondansetron; systemic, rectal
60.0
168.0
100
28
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
150.0
128
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
136.8
118
*
A03FA01
ATC
metoclopramide; systemic, rectal
18.2
122.0
158
225
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
80.8
73
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
77.3
70
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
25.4
72.6
54
27
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
17.0
70.3
65
51
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
27.5
65.8
47
21
JAL30
NOMESCO Finland
Omentectomy
131.1
64.7
67
7
JN4BD
NOMESCO Finland
Extensive body CT
14.4
62.6
64
59
L03AA02
ATC
filgrastim; parenteral
+∞
55.4
51
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
17.3
55.2
49
35
L03AA13
ATC
pegfilgrastim; parenteral
590.4
50.3
48
*
JEA00
NOMESCO Finland
Appendectomy
14.4
49.6
49
42
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
+∞
48.6
45
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
486.1
42.5
41
*
A04AA02
ATC
granisetron; systemic, transdermal
457.6
40.3
39
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
39.7
37
*
A04AA03
ATC
tropisetron; systemic
+∞
38.6
36
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
12.7
37.4
39
36
R18
ICD-10 Finland
Ascites
81.7
37.3
41
6
ZX120
NOMESCO Finland
Intravenous
8.7
35.8
51
72
L02BG04
ATC
letrozole; oral
398.1
34.9
34
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
34.2
32
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
34.2
32
*
Z51.5
ICD-10 Finland
Palliative care
9.6
33.6
43
53
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
33.1
31
*
LCD00
NOMESCO Finland
Hysterectomy
8.2
32.3
48
71
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
32.0
30
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
8.3
29.9
43
61
L02BA01
ATC
tamoxifen; oral
+∞
29.8
28
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
28.7
27
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
5.4
26.9
65
155
A98
ICPC
Health maint/preventive medicine
0.2
26.0
153
2144
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
25.5
24
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
24.4
23
*
JAH01
NOMESCO Finland
Laparoscopy
9.6
24.2
30
35
WX302
NOMESCO Finland
Thoracal epidural anesthesy
20.3
21.5
32
18
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
21.1
20
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
21.1
20
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.9
20.6
52
127
JN4AD
NOMESCO Finland
Body CT examination
6.4
20.1
36
64
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
20.1
19
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
20.1
19
*
HA1AA
NOMESCO Finland
X-ray mammography
7.6
20.0
30
44
JAH00
NOMESCO Finland
Laparotomy
16.7
19.5
31
21
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
42.1
18.9
23
6
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
4.4
18.4
54
148
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
17.4
18.0
28
18
B01AB05
ATC
enoxaparin; parenteral
3.2
17.5
118
556
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
16.9
16
*
115
Kela drug reimbursment
Breast cancer
+∞
16.9
16
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
16.9
16
*
WW500
NOMESCO Finland
Blood transfusion
15.0
16.4
27
20
ZXE20
NOMESCO Finland
More than three and less than five hours
4.0
16.0
53
158
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.8
15.8
26
42
8102
FHL
Second look"" surgery for a malignant tumor
+∞
15.8
15
*
Z31.5
ICD-10 Finland
Genetic counselling
12.0
14.9
27
25
130
Kela drug reimbursment
Malignant tumour
+∞
14.7
14
*
N02AA05
ATC
oxycodone; systemic
3.2
14.0
72
284
121
Kela drug reimbursment
Severe hypofunction of sexual glands
12.0
13.9
25
23
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
6.4
13.8
24
41
L01CB01
ATC
etoposide; systemic
+∞
13.7
13
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
13.7
13
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
13.7
13
*
TJA10
NOMESCO Finland
Laparocentesis
147.9
13.6
14
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.8
13.0
102
505
B01AB10
ATC
tinzaparin; parenteral
4.1
12.8
39
109
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.7
12.7
45
140
C567, ,
ICD-10 Finland
+∞
12.6
12
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
12.6
12
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
12.6
12
*
A04AD12
ATC
aprepitant; systemic
+∞
12.6
12
*
JAL00
NOMESCO Finland
Biopsy of peritoneum
49.3
12.0
14
*
WZC00
NOMESCO Finland
Treatment plan or consultation
2.7
11.9
87
412
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
12.0
11.8
21
19
1XC07, ,
NOMESCO Finland
+∞
11.5
11
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
11.5
11
*
TLE30
NOMESCO Finland
Tamponation of vagina
+∞
11.5
11
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
11.5
11
*
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
11.5
11
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
45.5
11.0
13
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
114.8
10.5
11
*
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
17.0
10.5
16
10
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
10.5
10
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
10.5
10
*
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
10.5
10
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
10.5
10
*
X77
ICPC
Malignant neopl genital female other
+∞
10.5
10
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
10.7
10.2
19
19
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
9.8
45
164
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
57.3
9.7
11
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
57.3
9.7
11
*
PJA12
NOMESCO Finland
Sentinel node biopsy
103.9
9.5
10
*
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
103.9
9.5
10
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
10.1
9.4
18
19
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
9.4
9
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.9
9.3
19
23
I10
ICD-10 Finland
Essential (primary) hypertension
0.4
9.1
105
1545
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
38.2
9.1
11
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.1
8.9
21
32
D70.82
ICD-10 Finland
Drug-induced neutropenia
93.2
8.5
9
*
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
8.4
8
*
1510
Kela drug reimbursment
Niraparib
+∞
8.4
8
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
8.4
8
*
3009
Kela drug reimbursment
Niraparib
+∞
8.4
8
*
JAL31
NOMESCO Finland
Laparoscopic omentectomy
+∞
8.4
8
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
8.4
8
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
15.2
8.3
13
9
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
22.9
8.1
11
5
N05AB04
ATC
prochlorperazine; systemic, rectal
4.7
8.0
19
43
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.8
7.9
19
30
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
25.9
7.6
10
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
82.5
7.5
8
*
B01AB04
ATC
dalteparin; parenteral
4.1
7.4
21
55
J94.8
ICD-10 Finland
Other specified pleural conditions
11.4
7.4
13
12
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
7.3
7
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
7.3
7
*
ZX121
NOMESCO Finland
Central venous catheter
+∞
7.3
7
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
7.3
7
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
L01XK02
ATC
niraparib; oral
+∞
7.3
7
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
16.4
7.3
11
7
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
16.4
7.3
11
7
HAB40
NOMESCO Finland
Wedge excision of mammary gland
20.8
7.2
10
5
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
12.5
7.2
12
10
RS220, ,
NOMESCO Finland
14.3
7.0
11
8
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.2
6.7
9
349
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
6.7
100
618
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
71.7
6.5
7
*
LAE20
NOMESCO Finland
Bilateral oophorectomy
71.7
6.5
7
*
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
+∞
6.3
6
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
+∞
6.3
6
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
6.3
6
*
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
+∞
6.3
6
*
A79
ICPC
Malignancy NOS
+∞
6.3
6
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
27.5
6.3
8
*
Z2446
NOMESCO Finland
Social worker
3.3
6.1
23
74
R2110
NOMESCO Finland
Giving the first information
3.3
6.1
23
74
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
132
2018
0.24
25.88
5.1
5.2
6.11
5.98
mmol/l
0.35
115
1800
125
1972
0.25
25.80
4.8
4.9
4.73
4.71
mmol/l
0.10
108
1771
133
2021
0.24
25.53
5.2
5.6
2.73
2.70
mmol/l
0.13
116
1815
117
1909
0.25
24.95
6.2
6.4
40.30
40.39
mmol/mol
0.04
101
1746
124
1948
0.26
24.12
4.8
4.8
1.58
1.60
mmol/l
0.22
106
1745
161
2153
0.25
21.27
34.4
20.7
37.80
38.90
%
1.80
149
1977
129
1941
0.29
20.45
6.7
5.7
2.11
2.00
mu/l
0.34
113
1750
155
2095
0.28
18.81
16.0
9.6
23.56
21.87
u/l
0.77
149
1995
122
1869
0.30
18.76
4.2
4.4
1.38
1.23
mmol/l
1.96
103
1651
157
2089
0.30
17.00
26.7
16.6
74.95
72.62
umol/l
0.39
157
2089
114
1671
0.40
11.05
5.9
4.6
15.21
15.11
pmol/l
0.16
102
1502
138
1867
0.40
10.99
21.2
13.2
72.13
72.01
ml/min/173m2
0.02
121
1475
37
111
3.75
10.92
3.3
1.3
10.54
2.80
ug/l
0.69
30
87
153
1966
0.40
10.08
19.4
14.0
31.63
20.78
mg/l
2.34
134
1503
113
1527
0.51
6.06
4.3
4.7
16.66
14.20
mm/h
0.68
101
1384
63
999
0.50
5.26
2.3
2.1
103.27
98.69
pmol/l
0.36
27
462
63
978
0.52
4.76
2.2
2.4
81.03
82.34
nmol/l
0.15
56
842
32
601
0.46
4.13
1.9
1.6
26.90
22.71
nmol/l
0.50
27
508
55
842
0.55
3.69
3.4
2.7
86.82
98.96
ug/l
0.57
47
743
14
47
3.10
3.47
1.0
1.4
—
—
—
0
0
18
371
0.44
2.89
3.8
2.6
1.11
1.81
e6/l
—
10
200
29
497
0.53
2.71
1.9
1.8
1153.29
1220.45
nmol/l
0.15
21
361
86
1116
0.64
2.68
4.2
2.9
60.01
44.61
u/l
0.79
78
1013
72
969
0.63
2.65
2.1
2.5
—
—
—
0
0
31
517
0.54
2.64
1.4
1.8
399.60
14851973.69
pmol/l
0.50
25
404
36
571
0.57
2.57
1.7
1.6
1.47
1.29
mmol/l
0.54
27
472
54
771
0.61
2.55
2.6
3.0
933.23
1503.73
ng/l
1.45
44
648
17
341
0.46
2.53
3.7
2.8
2.93
4.53
e6/l
—
9
171
50
721
0.61
2.44
3.4
3.6
2.54
4.46
mg/mmol
0.71
25
422
5
8
6.35
2.38
1.0
1.3
493.00
129.13
u/l
—
5
8
31
183
1.80
2.21
2.6
1.4
63.98
67.22
g/l
1.23
25
157
40
591
0.61
2.12
3.6
3.2
0.31
0.55
e6/l
0.98
33
457
13
258
0.48
1.88
1.3
1.4
—
—
—
0
0
89
1096
0.70
1.87
6.0
5.0
1.21
1.23
mmol/l
1.05
76
949
106
1240
0.74
1.48
4.5
3.9
6.60
6.68
mmol/l
0.26
100
1139
89
1063
0.74
1.41
5.3
4.4
0.00
0.02
estimate
0.50
24
188
89
1060
0.75
1.38
6.3
6.0
0.00
0.00
estimate
-0.00
24
182
73
888
0.75
1.28
3.1
4.0
17.82
134.20
ng/l
0.90
55
675
11
201
0.53
1.28
1.4
1.7
770.45
379.38
nmol/l
1.14
11
186
90
1055
0.77
1.19
5.1
4.4
0.00
0.01
estimate
0.50
25
207
10
50
2.04
1.18
1.5
2.4
—
—
—
0
0
7
30
2.37
1.13
1.0
1.4
—
—
—
0
0
35
461
0.72
1.01
4.1
2.3
2.55
2.47
mmol/l
3.13
30
395
44
558
0.74
1.00
2.3
2.3
3.03
3.07
mg/l
0.05
34
464
85
987
0.79
1.00
5.4
4.7
1.22
1.23
mmol/l
0.50
77
876
34
447
0.72
0.97
3.1
4.4
36.06
135.13
ng/l
1.11
25
372
0
31
0.00
0.97
0.0
1.5
—
—
—
0
0
37
477
0.74
0.94
2.5
2.2
11327.35
6814.15
umol/l
0.16
31
395
62
742
0.78
0.92
3.0
3.2
—
—
—
0
0
68
803
0.79
0.90
6.0
4.7
—
—
—
0
0
112
992
1.24
0.89
7.4
3.4
8.72
10.63
umol/l
3.12
107
917
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
0
26
0.00
0.79
0.0
1.4
—
—
—
0
0
0
27
0.00
0.78
0.0
1.2
—
—
—
0
0
8
134
0.58
0.76
1.6
1.9
—
—
—
0
0
35
440
0.76
0.75
1.2
1.3
0.62
1.44
u/ml
—
10
106
29
367
0.76
0.66
1.2
1.3
7.31
16.01
u/ml
0.83
11
120
30
377
0.77
0.65
1.2
1.3
50.89
49.44
iu/ml
—
9
123
27
342
0.76
0.62
1.6
1.9
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
73
643
1.19
0.58
2.0
2.1
44.99
61.78
u/l
3.40
67
578
12
170
0.69
0.55
2.0
2.3
4.13
4.44
kpa
0.38
12
163
15
203
0.72
0.54
3.1
2.5
5.84
5.89
kpa
0.06
15
196
7
45
1.57
0.49
4.3
4.2
33.43
31.61
mg/l
—
7
29
143
1513
0.87
0.48
8.9
5.4
92.20
77.34
u/l
1.29
137
1379
36
422
0.83
0.44
1.4
1.6
1.25
1.06
mg/l
0.23
28
322
49
429
1.18
0.43
2.4
1.9
—
—
—
0
0
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
62
554
1.16
0.42
5.7
4.6
0.00
0.00
estimate
-0.00
23
182
113
1054
1.13
0.41
16.4
5.9
4.04
4.28
e9/l
0.62
105
896
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
0
17
0.00
0.41
0.0
2.2
—
—
—
0
0
0
19
0.00
0.39
0.0
3.4
—
—
—
0
0
24
288
0.82
0.38
11.0
7.8
—
—
—
0
0
5
78
0.63
0.36
1.6
1.7
—
144.00
—
0
5
30
348
0.84
0.34
1.4
1.4
—
—
—
0
0
14
176
0.78
0.33
6.4
3.9
1.19
1.45
mmol/l
0.77
14
171
15
121
1.26
0.29
1.7
1.5
—
—
—
0
0
25
214
1.19
0.29
3.4
3.1
—
—
—
0
0
18
149
1.22
0.28
4.1
2.4
55.00
58.38
ml/min/173m2
—
9
56
15
181
0.82
0.26
2.5
2.1
29.07
28.82
u/l
0.04
15
146
21
242
0.86
0.23
1.5
1.9
—
—
—
0
0
5
39
1.29
0.23
3.8
2.3
70.00
59.18
%
—
5
39
7
91
0.76
0.23
1.3
1.3
—
—
—
0
0
7
91
0.76
0.23
1.3
1.3
3.49
3.64
g/l
—
7
78
7
91
0.76
0.23
1.3
1.3
7.23
7.72
g/l
—
7
78
7
91
0.76
0.23
1.3
1.4
9.03
10.45
g/l
—
7
77
0
11
0.00
0.21
0.0
1.1
—
0.60
—
0
6
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
2.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
2.0
—
1614.50
—
0
12
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
9
112
0.80
0.20
1.3
2.2
0.62
0.65
%
—
9
112
9
114
0.78
0.20
1.7
2.5
24.24
25.63
mmol/l
—
9
109
0
14
0.00
0.20
0.0
1.0
—
40.00
—
0
8
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
691.86
—
0
7
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
7
59
1.19
0.18
1.3
1.3
—
—
—
0
0
6
78
0.76
0.16
1.2
1.3
—
3.71
—
0
21
6
79
0.75
0.15
1.3
1.6
0.97
1.72
ug/l
—
6
68
9
81
1.12
0.15
1.7
1.9
112.33
2730.13
ug/l
—
9
75
22
241
0.90
0.12
1.6
1.8
—
—
—
0
0
10
115
0.86
0.11
1.5
2.2
1.34
1.14
%
—
10
115
6
56
1.07
0.08
1.0
1.3
—
—
—
0
0
6
71
0.84
0.07
1.2
1.4
1.50
0.62
g/l
—
6
58
6
72
0.83
0.07
1.2
1.3
36.38
37.60
g/l
—
6
59
8
77
1.04
0.07
1.1
1.2
—
—
—
0
0
8
77
1.04
0.07
1.1
1.2
—
—
—
0
0
7
81
0.86
0.07
1.3
1.4
3.23
3.09
g/l
—
7
68
99
1010
0.97
0.07
15.2
15.2
1.37
1.30
inr
0.24
33
291
8
90
0.89
0.07
1.8
1.6
—
—
—
0
0
9
100
0.90
0.06
1.9
2.5
0.27
0.16
e6/l
—
9
94
9
100
0.90
0.06
1.1
1.3
—
—
—
0
0
14
142
0.99
0.00
1.5
1.6
—
—
—
0
0
85
846
1.01
0.00
2.7
2.2
—
—
—
0
0
91
914
0.99
0.00
5.4
3.3
32.36
35.20
g/l
3.38
84
829
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
64
0.94
0.00
1.2
1.4
0.00
0.09
g/l
—
6
57
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
10.62
—
0
9
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
103.00
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
62
0.97
-0.00
1.2
1.3
0.00
0.00
g/l
—
6
56
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
6
63
0.95
-0.00
1.2
1.3
0.00
0.00
g/l
—
6
57
9
94
0.96
-0.00
1.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
55
0.91
-0.00
1.6
1.8
—
—
—
0
0
6
68
0.88
-0.00
1.2
1.3
—
3.37
—
0
7
0
6
0.00
-0.00
0.0
3.0
—
1.18
—
0
6
0
9
0.00
-0.00
0.0
4.1
—
208.89
—
0
9
6
69
0.87
-0.00
1.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_OVARY_SEROUS – Serous carcinoma of ovary
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).